Publications by authors named "Frida E Sander"

Claim this Profile
C
c-FLIP and CD95 signaling are essential for survival of renal cell carcinoma.
Tobias Luebke, Lisa Schwarz, Yan Yan Beer, Sabrina Schumann, Maria Misterek, Frida Ewald Sander

Cell Death Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
Hanna Grauers Wiktorin, Malin S Nilsson, Roberta Kiffin, Frida Ewald Sander, Brianna Lenox

Cancer Immunol Immunother· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia.
Elin Bernson, Alexander Hallner, Frida E Sander, Malin Nicklasson, Malin S Nilsson

Cancer Immunol Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.
Frida Ewald Sander, Malin Nilsson, Anna Rydström, Johan Aurelius, Rebecca E Riise

Cancer Immunol Immunother· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia.
Anna Rydström, Alexander Hallner, Johan Aurelius, Frida Ewald Sander, Elin Bernson

J Leukoc Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia.
Frida Ewald Sander, Anna Rydström, Elin Bernson, Roberta Kiffin, Rebecca Riise

Oncotarget· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia.
Alexander Hallner, Johan Aurelius, Fredrik Bergh Thorén, Frida Ewald Sander, Mats Brune

Eur J Haematol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis